编码核孔蛋白GP210的NUP210基因功能性多态性与子宫内膜异位症风险相关
本研究探讨核孔蛋白210(GP210,由NUP210基因编码)是否参与子宫内膜异位症。采用免疫组化荧光检测组织表达、病例对照研究分析rs354476与风险关联、体外荧光素酶试验评估功能活性。结果发现GP210在子宫内膜腺上皮细胞核阳性表达,变异等位基因携带者风险增加:C/T OR 1.83(95%CI 1.04-3.21),T/T OR 2.55(95%CI 1.36-4.80);rs354476为hsa-miR-125b-5p的靶点。
要点
- GP210在子宫内膜腺上皮细胞核呈阳性免疫荧光染色。
- NUP210 rs354476变异等位基因携带者子宫内膜异位症风险增加:C/T OR 1.83,T/T OR 2.55。
- rs354476通过改变与hsa-miR-125b-5p结合调控NUP210表达。
核心结论
- 核孔蛋白GP210参与子宫内膜异位症。
- rs354476多态性通过改变与hsa-miR-125b-5p的结合影响NUP210基因表达调控,为变异等位基因携带者子宫内膜异位症风险增加提供依据。
研究设计与样本
- 免疫组化荧光分析检测患者与对照子宫内膜组织中GP210表达。
- 基因分型及病例对照研究评估NUP210基因rs354476与子宫内膜异位症风险的关联。
- 体外荧光素酶试验评估rs354476的功能活性。
- 组织学诊断的子宫内膜异位症病例175例:轻微或轻度(I-II期)48例(28%),中度(III期)69例(39%),重度(IV期)58例(33%);对照557例为佛罗伦萨Meyer医院女性献血者。
主要发现
- GP210在子宫内膜腺上皮细胞核呈阳性免疫荧光染色。
- 变异等位基因携带者风险增加:C/T OR 1.83(95%CI 1.04-3.21);T/T OR 2.55(95%CI 1.36-4.80)。
- 体外荧光素酶试验显示rs354476是hsa-miR-125b-5p的真正靶点。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether nucleoporin 210 (GP210, encoded by NUP210 gene) is involved in endometriosis. DESIGN: Immunohistofluorescence analysis for assessing whether GP210 is expressed in endometrial tissues from patients and controls; genotyping and case-control study for assessing the association between rs354476 within NUP210 and risk of endometriosis; in vitro luciferase assay for assessing the functional activity of rs354476. SETTING: University. PATIENT(S): Histologically diagnosed cases (n = 175) of endometriosis: minimal or mild (stage I-II) in 48 cases (28%), moderate (stage III) in 69 cases (39%), and severe (stage IV) in 58 cases (33%). Controls (n = 557) were female blood donors collected at Meyer Hospital of Florence. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): GP210 tissue expression; genotype distribution and risk of endometriosis; in vitro gene expression measurements. RESULT(S): GP210 had positive nuclear immunohistofluorescence staining in endometrial glandular epithelium. Carriers of the variant allele were associated with increased risks: C/T, odds ratio (OR) 1.83, 95% confidence interval (CI) 1.04-3.21; T/T, OR 2.55, 95% CI 1.36-4.80. In vitro, luciferase assay showed that rs354476 is a bona fide target for hsa-miR-125b-5p. CONCLUSION(S): Nucleoporin GP210 is involved in endometriosis. Rs354476 polymorphism affects the regulation of NUP210 gene expression by altering the binding with hsa-miR-125b-5p, a microRNA already known as playing an important role for endometriosis. This provides the rationale for the observed increased risk of endometriosis in carriers of the variant allele.
引用
- Cipollini M, Luisi S, Piomboni P, et al. Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis. Fertil Steril. 2019. PMID: 31256999. doi:10.1016/j.fertnstert.2019.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。